Oracle Life Sciences Study: 60-minute telephone interview for people diagnosed with schizophrenia and caregivers / family members of people diagnosed with schizophrenia.

Oracle Life Sciences and Global Perspectives are conducting a study to learn more about people diagnosed with schizophrenia and their caregivers or family members and are looking for participants.

Eligible participants are those who are 18 years or older and have experience with UZEDY (risperidone), a long acting injectable (LAI).  If qualified, you will participate in an interview which will last approximately 60 minutes and will provide you with $62.50 for your participation.

Any information you provide us with will be treated as confidential and taking this opportunity to have your voice heard would greatly help us further our research. Your participation would be hugely appreciated. If you have any questions, please contact us at nina.alonso@iqvia.com.